<?xml version="1.0" encoding="UTF-8"?>
<p id="p0055">A few 
 <italic>in vitro</italic> studies have also investigated the utility of remdesivir against non-human CoVs. For example, a study by Murphy et al. reported anti-CoV activity of remdesivir's parent nucleoside, GS-441524, against an alphacoronavirus that only infects wild and domestic cats, the feline infectious peritonitis (FIP) virus (EC
 <sub>50</sub> = 0.78 μM; 
 <xref rid="t0005" ref-type="table">Table 1</xref>) [
 <xref rid="bb0070" ref-type="bibr">14</xref>]. In 2019, Brown et al. observed some antiviral effects of remdesivir against SARS-like bat CoVs (specifically, Bat-CoV HKU3, Bat-CoV SCH014, and Bat-CoV WIV1) and MERS-like bat CoVs (specifically, Bat-CoV HKU5) [
 <xref rid="bb0060" ref-type="bibr">12</xref>].
</p>
